Abstract
The rapid-cycling variant of bipolar disorder (RCBD) has been variably defined, with episode frequencies ranging from several per day to a minimum of four per year. It is diagnosed disproportionately in women with bipolar II disorder. Its time of onset may be in childhood, adolescence, or adulthood. It appears to be treatment refractory, but controlled trials are lacking. Concurrent treatment with lithium and an antiepileptic drug is considered the current mainstay of treatment, and antidepressants are discouraged. Controlled trials in homogenous cohorts of RCBD patients are needed. Preliminary data suggest that two or more mood stabilizers are required for adequate control.
Similar content being viewed by others
References and Recommended Reading
Kraepelin E:Psychiatrie III, Klinische Psychiatrie II. Leipzig: Verlag von Johann Ambrosius Barth; 1913.
Dunner D, Feive R: Clinical problems in lithium prophylaxis failure. Arch Gen Psychiatry 1974, 20:229–233.
Bauer MS, Calabrese JR, Dunner DL, et al.: Multi-site data reanalysis: validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994, 151:506–515.
Maj M, Pirozzi R, Formicola A, Totorella A: Reliability and validity of four alternative definitions of rapid-cycling bipolar disorder. Am J Psychiatry 1999, 156:1421–1424.
Coryell W, Endicott J, Keller M: Rapidly cycling affective disorder: demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992, 49:126–131.
Kramlinger K, and Post R: Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry 1996, 168:314–323.
Kukopulos A, Reginaldi D, Laddomada P, et al.: Course of the manic depressive cycle and changes caused by treatment. Pharmacopsychiatry 1980, 13:156–167.
Tondo L, and Baldessarini R: Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry 1998, 155:1434–1436.
Weissman M, Leaf P, Tischler G, et al.: Affective disorders in five United States communities. Psychol Med 1988, 18:141–153.
Price W, and DiMarzio L: Premenstrual tension syndrome in rapid-cycling bipolar disorder. J Clin Psychiatry 1986, 47:415–417.
WehrT: Causes and treatments of rapid-cycling affective disorder. InPharmacotherapy of Depression: Applications for the Outpatient Practitioner. Edited byAmsterdamJ. New York: Marcel Dekker; 1990:401–426.
Leibenluft E, Ashman S, Feldman-Naim S, Yonkers K: Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder. Biol Psychiatry 1999, 46:577–580.
Post RM, Kramlinger KG, Joffe RT, et al.: Rapid cycling bipolar affective disorder: lack of relation to hypothyroidism. Psychiatry Res 1997, 72:1–7.
Regier D, Farmer M, Rae DD, et al.: Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511–2518.
Haywood T, Kravitz H, Grossman L, et al.: Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 1995, 152:856–861.
Sonne S, Brady K, Morton W: Substance abuse and bipolar affective disorder. J Nerv Ment Dis 1994, 182:349–352.
Brady K, Casto S, Lydiard R, et al.: Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 1991, 17:389–397.
Puig-AntichJ: Affective disorders in childhood, a review and perspective. Psychiatric Clin North America 1980, 3:403–423.
Weller R, Weller E, Tucker S, Fristad M: Mania in prepubertal children: has it been underdiagnosed? J Affect Disord 1986, 11:151–154.
Geller B, Sun K, Zimerman B, et al.: Complex and rapid-cycling in bipolar children and adolescents: a preliminary study. J Affect Disord 1995, 34:259–268.
Maj M, Pirozzi R, Magliano L, Bartoli L: Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998, 155:30–35. This study provides evidence suggesting that lithium in monotherapy or in combination therapy is largely unhelpful in maintenance treatment of RCBD.
Tondo L, Baldessarini R, Hennen J, Floris G: Lithium maintenance treatment of depression and mania in Bipolar I and Bipolar II disorders. Am J Psychiatry, 1998, 155:638–645.
Calabrese J, Bowden C, Woyshville M: Lithium and anticonvulsants in the treatment of bipolar disorder. InPsychopharmacology: The Third Generation of Progress. Edited by BloomE and Kupfer D. New York: Raven Press; 1995:1099–1112.
Calabrese J, Woyshville M, Kimmel S, Rapport D: Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacology 1993, 13:280–283.
Post R, Uhde T, Roy-Byrne R, Joffe R: Correlates of antimanic response to carbamazepine. Psychiatry Res 1987, 21:71–83.
Denikoff K, Smith-Jackson E, Disney E, et al.: Comparative prophylactic efficiency of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997, 58:470–478. This is the only prospective, double-blind, random-assignment study of the efficacy of carbamazepine in the treatment of RCBD.
OkumaT: Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 1993, 27:138–145.
JoyceP: Carbamazepine in rapid cycling bipolar disorder. Int Clin Psychopharmacol 1988, 3:123–129.
Calabrese J, Rapport D, Shelton M, Kimmel S: Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology 1998, 38:185–191.
Bowden CL, Calabrese JR, McElroy SL, et al.: The efficacy of lamotrigine in rapid cycling and non-rapid cycling bipolar disorder. Biol Psychiatry 1999, 45:953–958.
Physician’s Desk Reference, edn 54. Montvale, NJ: Medical Economics Data Production Company; 2000.
Calabrese JR, Bowden C, Sachs G, et al., for the Lamictal 602 Study Group: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999, 60:79–88. This is the first randomized, double-blind, parallel-group, placebocontrolled evaluation of lamotrigine efficacy in the treatment of bipolar-I depression; results suggest marked antidepressant efficacy is seen, and that lamotrigine may have special utility in the treatment of RCBD.
Gordon A, Price L: Mood stabilization and weight loss with topiramate. Am J Psychiatry 1999, 156:968A-969.
MarcotteD: Use of topiramate, a new anti-epileptic, as a mood stabilizer. J Affect Disorder 1998, 50:245–251.
Sachs G, Gaughan S, Koslow C, et al.:Topiramate in the treatment of refractory bipolar mood disorder [abstract], oral presentation W8-2. Third International Congress of Neuropsychiatry. Kyoto, Japan: April 9–13 2000.
Chengappa K, Rathore D, Levine J, et al.: Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999, 1:42–53.
McElroy S, Soutillo C, Keck P: A pilot trial of adjunctive gabapentin therapy in the treatment of bipolar disorder. Ann Clin Psychiatry 1997, 9:99–103.
Pande et al.: Biol Psychiatry 2000, in press.
Calabrese J, Meltzer H, Markovitz P: Clozapine prophylaxis in rapid-cycling bipolar disorder [letter]. J Clin Psychopharmacology 1991, 11:396–397.
Kimmel S, Calabrese J, Woyshville M, Meltzer H: Clozapine in treatment-refractory mood disorders. J Clin Psychiatry 1994, 55(Suppl B):91–93.
Calabrese J, Kimmel S, Woyshville M, et al.: Clozapine for treatment-refractory mania. Am J Psychiatry 1996, 153:759–764.
Suppes T, Phillips K, Judd R: Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry 1994, 36:338–340.
Suppes T, Webb A, Paul B, et al.: Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999, 156:1164–1169. This is the first controlled trial of clozapine add-on therapy in treatment-refractory bipolar patients with and without RCBD.
Berman E, Wolpert E: Intractable manic depressive psychosis with rapid cycling in an 18 year old woman successfully treated with electroconvulsive therapy. J Nerv Ment Dis 1987, 175:236–239.
Vanelle J-M, Loo H, Galinowski A, et al.: Maintenance ECT in intractable manic depressive disorders. Convuls Ther 1994, 10:195–205.
Frye M, Ketter T, Leverich G, et al.: The increasing use of polypharmacy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000, 61:9–14. Documentation and discussion of the phenomenon and its implications.
CochranS: Preventing medical noncompliance in outpatient treatment of bipolar affective disorders. J Consult Clin Psychology 1984, 52:873–878.
Stoll A, Severus W, Freeman M, et al.: Omega-3 fatty acids in bipolar disorder: a preliminary double-blind, placebocontrolled trial. Arch Gen Psychiatry 1999, 56:407–412.
Stoll A, Sachs G, Cohen B, et al.: Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry 1996, 40:382–388.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shelton, M.D., Calabrese, J.R. Current concepts in rapid cycling bipolar disorder. Curr Psychiatry Rep 2, 310–315 (2000). https://doi.org/10.1007/s11920-000-0073-8
Issue Date:
DOI: https://doi.org/10.1007/s11920-000-0073-8